Your browser doesn't support javascript.
loading
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.
Badiginchala, Revathi; Dattatreya, Palanki Satya; Suresh, Attili Venkata Satya; Nirni, Sharanabasappa Somanath; Andra, Vindhya Vasini; Bunger, Deepak; Chaturvedi, Alok.
Affiliation
  • Badiginchala R; Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India.
  • Dattatreya PS; Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India.
  • Suresh AVS; Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India.
  • Nirni SS; Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India.
  • Andra VV; Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India.
  • Bunger D; Medical Affairs, Intas Pharmaceuticals Limited, Ahmedabad, India.
  • Chaturvedi A; Medical Affairs, Intas Pharmaceuticals Limited, Ahmedabad, India.
Onco Targets Ther ; 16: 215-225, 2023.
Article in En | MEDLINE | ID: mdl-37033671
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Onco Targets Ther Year: 2023 Document type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Onco Targets Ther Year: 2023 Document type: Article Affiliation country: India